Share Prices & Company Research

Market News

20 Jan 2021 | 10:05

MaxCyte revenue growth expected to accelerate faster than anticipated

(Sharecast News) - Cell engineering specialist MaxCyte said on Wednesday that 2021 revenues were likely to grow at a faster than initially expected rate at the same time as it posted a solid set of earnings for 2020. MaxCyte stated turnover for the year ended 31 December advanced 21% to $26.2m on the back of an "increasing adoption and use" of its technology and the launch of an expanded range of disposables.

While the AIM-listed group acknowledged Covid-19 had some negative impact, revenue growth continued in the second half, increasing approximately 15% year-on-year.

Cash and cash equivalents, including short-term investments, at year-end, were approximately $34.8m following the firm's successful $30.5m financing in May 2020.

As far as the current year was concerned, MaxCyte said it was "fully focused" on expanding its core business and expects to deliver accelerating revenue growth in 2021, supported by both the continued advancement of its current partners' cell therapy programs into clinical development and the subsequent realisation of associated pre-commercial milestone payments, as well as by the addition of new customers via the conversion of "a burgeoning partnership pipeline".

Chief executive Doug Doerfler said: "The board is confident regarding the outlook for the company and we look forward to building on MaxCyte's strong operational foundation and performance of about 25% compound annual revenue growth over the past five years.

"Cell-based therapies continue to demonstrate tremendous promise in the treatment of patients with intractable disease and we believe MaxCyte's next-generation technology is uniquely placed to enable the development of these therapies."

As of 1000 GMT, MaxCyte shares were down 3.97% at 605.0p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.